Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04555902 · ClinicalTrials.gov registry record · NA
Evaluation of Mailers Promoting Mammogram Screening
A NA study of Breast Cancer, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 1,342
- Enrollment target
- 1
- Study location
NCT04555902: Completed NA study of Breast Cancer, sponsored by Geisinger Clinic.
NCT04555902 is a NA study of Breast Cancer that has completed, run by Geisinger Clinic. The registered enrollment target is 1,342 participants, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (52% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04555902, a NA study of Breast Cancer, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,342 participants
- Enrollment target
- 1
- Study location
Study Summary
In this evaluation, 3 different versions of mailers promoting annual mammograms are being sent to women on the month of their 50th and 64th birthdays. The researchers hypothesize that the use of behavioral nudges in the mailers should lead to increased uptake in mammogram screening.
Primary Outcome
Binary variable indicating whether a mammogram was completed
Conditions Studied
Interventions
- BEHAVIORAL Postcard
- BEHAVIORAL Small Gift
- BEHAVIORAL Loss Frame and Fear Appeals
Study Locations (1)
Pennsylvania
- Geisinger - Danville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,342 participants |
| Start Date | 2020-10-02 |
| Est. Completion | 2021-10-05 |
| Phase | NA |
What the finished NCT04555902 record still lists
NCT04555902 is an interventional study that assigns participants to a tested intervention. Its 1,342 participants enrollment target places it among the larger protocols in the corpus, below the 2,802-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (52% lower).
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 3 interventions - of which Postcard is the first listed.
NCT04555902 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04555902 about?
NCT04555902 is a clinical study titled "Evaluation of Mailers Promoting Mammogram Screening". In this evaluation, 3 different versions of mailers promoting annual mammograms are being sent to women on the month of their 50th and 64th birthdays. The researchers hypothesize that the use of behavioral nudges in the mailers should lead to increased uptake in mammogram screening.
What is the current status of trial NCT04555902?
This trial is currently completed. It is a NA study. The enrollment target is 1,342 participants. The study started on 2020-10-02. Estimated completion is 2021-10-05.
What conditions does trial NCT04555902 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT04555902?
The interventions under investigation include: Postcard (BEHAVIORAL), Small Gift (BEHAVIORAL), Loss Frame and Fear Appeals (BEHAVIORAL).
Who is sponsoring clinical trial NCT04555902?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04555902 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04555902's enrollment target sits among peer trials
1,342 93rd of 1224 higher than 1,132 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
-
Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)
RECRUITING · NA
-
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
RECRUITING · NA
-
A Randomized Controlled Trial (RCT) to Determine the Efficacy of a Multidisciplinary CBT Based Pain Management Program for the Treatment of Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS) in Breast Cancer Survivors
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06731608 · 1,344 participants · NA
OsteoPorotic fracTure preventION System (OPTIONS) Research Study
- NCT06972056 · 1,335 participants · Phase 4
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- NCT06318169 · 1,350 participants · Phase 3
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- NCT06605404 · 1,350 participants
Pan-tumor MRD Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI